The NICE Prioritisation Board (PB) met on Monday 16 June 2025 to consider the findings of the scoping exercise for this topic. PB subsequently agreed that low-dose atropine eye drops for treating myopia in people 3 to 14 years, should be selected for evaluation and ministerial referral from the Department of Health and Social Care (DHSC) will now be sought